Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G2E3 antisense RNA 1 (G2E3-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the G2E3 gene locus. Antisense RNAs such as G2E3-AS1 are generally involved in the regulation of gene expression at transcriptional and post-transcriptional levels, frequently through RNA:RNA interactions, transcriptional interference, or chromatin modification at or near their locus of origin[2]. Most characterized antisense RNAs function locally (in cis) to modulate the expression of an overlapping protein-coding gene, but specific functions of G2E3-AS1 remain undocumented in the available literature. No pharmacological agents or therapeutic relevance are established for this transcript. The G2E3 gene itself encodes a ubiquitin ligase implicated in cell cycle regulation, but G2E3-AS1 is a distinct, non-coding entity.\n\nKey points clarifying this entry:\n- G2E3-AS1 is not a receptor, enzyme, transporter, or classical therapeutic target[2].\n- It is not a well-characterized RNA—no drugs or biomarker utility identified.\n- The target name, aliases, and abbreviations are correct for a lncRNA antisense transcript.\n- All canonical information (mechanistic, disease relevance, molecular classification) is supported by general antisense RNA literature, not by molecule-specific reports for G2E3-AS1.\n\nIf your aim is to annotate *protein-coding targets* (such as receptors or enzymes), **G2E3-AS1 does not fit** the standard definition and should be classified accordingly. If spatial or transcriptional regulation of G2E3 by G2E3-AS1 is later confirmed in primary literature, the above assessment should be updated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G2E3 antisense RNA 1 (G2E3-AS1).